Full name
SKINCAN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
72.11.Z - Research and experimental development on biotechnology
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | -∞ |
EBITDA | 0 | 0 | -∞ |
Short time liabilities | 0 | 0,1 | -∞ |
Equity capital | 0 | 0,2 | -∞ |
Operating profit (EBIT) | 0 | 0 | -∞ |
Assets | 0 | 1,2 | -∞ |
Net profit (loss) | 0 | 0 | -∞ |
Cash | 0 | 0 | -∞ |
Liabilities and provisions for liabilities | 0 | 1 | -∞ |
Net income from sale | 0 | 0 | -∞ |
Working assets | 0 | 1,2 | -∞ |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 0,2 | ||
Equity capital to total assets | 18,8 | ||
Gross profit margin | 100 | ||
EBITDA Margin | 100 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 70 014 | 70 014 |
Current financial liquidity indicator | 1.231066346168518 | ||
Net dept to EBITDA | 184.14378356933594 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane